GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (SGX:H02) » Definitions » Sale Of Investment

Haw Par (SGX:H02) Sale Of Investment : S$522.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 1969. Start your Free Trial

What is Haw Par Sale Of Investment?

Haw Par's sale of investment for the six months ended in Dec. 2023 was S$322.9 Mil. It means Haw Par gained S$322.9 Mil from selling investments. Haw Par's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was S$522.9 Mil.

Compared with last quarter (S$200.0 Mil in Jun. 2023 ), Haw Par gained more money from selling investments in Dec. 2023 (S$322.9 Mil).

Haw Par Sale Of Investment Historical Data

The historical data trend for Haw Par's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haw Par Sale Of Investment Chart

Haw Par Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.34 64.05 5.54 - 522.91

Haw Par Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 200.00 322.91

Haw Par Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$522.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haw Par Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Haw Par's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Haw Par (SGX:H02) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (SGX:H02) » Definitions » Sale Of Investment
Comparable Companies
SGX:MV4 SGX:EB5 SGX:BEW SGX:CGN SGX:P8Z SGX:BKV SGX:5JS SGX:P34 SGX:F99 SGX:BNE LLY JNJ MRK ABBV LSE:AZN XSWX:ROG XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
HAWPF:USA
Address
401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Website
https://www.hawpar.com
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par (SGX:H02) Headlines

No Headlines